NLS PHARMACEUTICS LTD's ticker is NLSPW and the CUSIP is H57830111. A total of 6 filers reported holding NLS PHARMACEUTICS LTD in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ayrton Capital LLC | 170,100 | $18,201 | 0.11% |
Altium Capital Management LP | 200,000 | $21,400 | 0.02% |
ARMISTICE CAPITAL, LLC | 500,000 | $53,500 | 0.00% |
CLEAR STREET LLC | 8,600 | $1 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Hudson Bay Capital Management LP | 100,000 | $10,200 | 0.00% |
External links
This page lists NLS PHARMACEUTICS LTD's shareholders in Q2 2023. To view NLS PHARMACEUTICS LTD's shareholder history, click here.